Abcam

Abcam plc is a global biotechnology company that specializes in the production and distribution of antibodies and related protein research tools. Founded in 1998 by Jonathan Milner, David Cleevely, and Tony Kouzarides in Cambridge, United Kingdom, Abcam has grown to become one of the leading suppliers in the scientific research community, providing products and services to life science researchers in over 130 countries.

History

Abcam was established with the aim of providing high-quality antibodies to the research community, with an initial focus on antibodies that were hard to source. The company's innovative approach to antibody production, validation, and distribution, coupled with a strong emphasis on customer service and technical support, quickly established it as a key player in the life sciences sector.

Over the years, Abcam has expanded its product range to include not only primary and secondary antibodies but also ELISA kits, proteins, peptides, and other related reagents. The company has also embraced digital platforms for the distribution and support of its products, making it easier for researchers to find and purchase the tools they need for their work.

Products and Services

Abcam offers a wide range of products and services designed to support the life sciences community in their research efforts. These include:

• Antibodies: A comprehensive range of high-quality primary and secondary antibodies validated for various applications, such as Western blot, immunohistochemistry, and flow cytometry.
• ELISA Kits: Kits designed for the detection of specific proteins or antigens in samples, useful in various research and diagnostic applications.
• Proteins and Peptides: High-purity proteins and peptides for use in a variety of experimental protocols.
• Reagents: A broad selection of reagents for research use, including buffers, dyes, and standards.

Research and Development

Abcam is committed to advancing scientific research through innovation. The company invests significantly in research and development (R&D) to improve existing products and develop new solutions that address the evolving needs of researchers. This includes the development of new antibody technologies and the exploration of novel applications for antibodies in research and diagnostics.

Corporate Responsibility

Abcam recognizes the importance of corporate responsibility and is dedicated to ethical business practices, sustainability, and supporting the scientific community. The company's initiatives include reducing environmental impact, promoting diversity and inclusion within the workforce, and supporting science education and research through grants and sponsorships.

Expansion and Acquisitions

To broaden its product offerings and strengthen its market position, Abcam has pursued a strategy of growth through acquisition. The company has acquired several smaller companies and product lines that complement its existing portfolio, allowing it to offer a more comprehensive range of products and services to its customers.

Conclusion

Abcam plc has established itself as a key provider of research tools to the life sciences community, with a reputation for quality, innovation, and customer service. As the company continues to grow and expand its product range, it remains committed to supporting researchers worldwide in their quest to understand the complexities of biology and disease.